Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127465901 | 12746590 | 1 | I | 20160825 | 0 | 20160915 | 20160915 | DIR | US-FDA-350692 | FDA-CTU | 50.00 | YR | F | N | 57.60000 | KG | 20160915 | N | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127465901 | 12746590 | 1 | PS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | Oral | Y | N | 0 | 1 | DF | COATED TABLET | BID | |||||
127465901 | 12746590 | 2 | C | VITAMIN C | ASCORBIC ACID | 1 | 0 | ||||||||||||
127465901 | 12746590 | 3 | C | 50 AND OVER MULTIVITAMIN | 2 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127465901 | 12746590 | 1 | Urinary tract infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127465901 | 12746590 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127465901 | 12746590 | Arthralgia | |
127465901 | 12746590 | Gait disturbance | |
127465901 | 12746590 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127465901 | 12746590 | 1 | 20160825 | 20160831 | 0 |